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Abstract 
New indolo- and pyrrolo-pyrimidines of type 1-4 were studied for their ability to form stable 
complexes with DNA fragments. The calculated free energies of binding were found in the range 
-8.39 ÷ -16.72 Kcal/mol. The docking studies revealed a common binding mode with the 
chromophore intercalated between GC base pairs whereas the side chain lies along the minor 
groove. 
 







DNA represents one of the most important molecular cellular targets of several chemotherapic 
drugs. Molecular recognition of DNA by small molecules and proteins is a fundamental problem 
in drug design. Polycyclic heterocycles having a planar structure can be effective pharmacophore 
moieties of DNA-interactive drugs because they can insert between the stacked base paired 
oligonucleotides. Moreover if they bear suitable side chains further interactions of these ligands 
with the other important architectural feature of DNA, its minor groove, can be envisaged. 
Relatively little is understood at present about the mode of action at the molecular level of the 
majority of minor groove-interacting drugs, although there is increasing evidence that may act by 
directly blocking or inhibiting protein–DNA recognition.1 
Among the different classes of antitumor drugs which interact with DNA the actinomycins, a 
family of chromopeptide antibiotics, represent a peculiar one that combines the two above 
mentioned features. The most representative derivative, Dactinomycin (Actinomycin D), has 
Issue in Honor of Prof. Vincenzo Tortorella ARKIVOC 2004 (v) 263-271 
ISSN 1424-6376 Page 264 ©ARKAT USA, Inc 
been extensively investigated: it binds to double-stranded DNA and the phenoxazone moiety 
intercalates between bases whereas the peptide substituents lie in the minor groove (Figure 1).2 
The biological activity appears to depend from a very slow rate of dissociation of the complex 
between DNA and the drug, which reflects the intermolecular hydrogen bonds, the planar 
interaction between the purine rings and the chromophore, and the numerous van der Waals 
























Figure 1. Actinomycin D (left) and X-Ray structure of Actinomycin D intercalated into a DNA 
fragment. 
 
In connection with our researches on polycondensed nitrogen heterocycles as potential DNA-
interactive drugs, we have already studied different classes of planar systems (either linear or 
angular) which incorporate the indole or pyrrole ring and that can be considered bioisosters of 
the pharmacophore of several classes of antitumor drugs including the actinomycins.3-9 Now our 
interest is focused on designing compounds that can form stable complexes with DNA and 
therefore we report docking studies on the new series of indolo- and pyrrolo-pyrimidines of type 
1-4 which show a planar moiety joined to an iminoalkylcarboxylate chain of variable length, 
with the aim of performing a fast in silico screening of new potential DNA-interactive drugs. 
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X=CH2, (CH2)2, (CH2)3, NMe, CHMe, CHMeCH2 
 
Fast computational tools are essential to most techniques for structure-based drug design. 
Reported procedures include docking simulation methods. These techniques can model the 
docking of a ligand to a target in greater detail: the ligand begins randomly outside the receptor, 
and explores translations, orientations, and conformations until an ideal site is found. These 
techniques are typically slower than other techniques, but they allow flexibility within the ligand 
to be modelled and can utilize more detailed molecular mechanics to calculate the energy of the 
ligand in the context of the putative active site. They allow medicinal chemists to investigate 




Results and Discussion 
 
The starting point of all docking calculations is generally the crystal structure of a 
macromolecule (enzyme, DNA or RNA fragments an so on) usually obtained from a 
macromolecule-ligand complex. This complex may be taken from a database of compounds, 
such as the Cambridge Crystallographic Database10 or the Protein Data Bank (PDB).11 The 
primary consideration in the design of a docking process has to be the development of methods 
which are both rapid and reasonably accurate. 
In any docking scheme two conflicting requirements must be balanced: the desire for a robust 
and accurate procedure, and the desire to keep the computational demands at a reasonable level. 
The ideal procedure would find the global minimum in the interaction energy between the 
substrate and the target receptor, exploring all available degrees of freedom (DOF) for the 
system. However, it must also run on a laboratory workstation within an amount of time 
comparable to other computations that a structural researcher may undertake, such as a 
crystallographic refinement. In order to meet these demands a number of docking techniques 
simplify the docking procedure. These programs can be separated functionally into roughly two 
parts, each somewhat independent of the other: 
 R1 R2 R3 
a H H Ph 
b H Ph Me 
c H Me Ph 
d H Me Me 
e H Ph H 
f H thien-2-yl H 
g H furan-2-yl H 
h CH2Ph H Ph 
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• Routines which determine the orientation and the position of a ligand relative to the 
receptor. 
• Routines which evaluate (score) the stability of the complex. 
Our studies were carried out, according to the procedure reported in the experimental section, 
by using the software package AutoDock.12 It combines a rapid energy evaluation through 
precalculated grids of affinity potentials with a variety of search algorithms to find suitable 
binding positions for a ligand on a given receptor. While the macromolecule is required to be 
rigid, the program allows torsional flexibility in the ligand. The program searches for the best 
conformation and for the best place of binding of the ligand within the receptor structure. Several 
runs of space search were carried out to find the best ligand-receptor binding arrangement. 
Docking to DNA fragment was performed using the Lamarckian Genetic Algorithm (LGA)13 and 
an empirical binding free energy function. 
The Protein Data Bank was searched for DNA fragments bound with intercalators and the 
structure 1DSC (an octamer complexed with Actinomycin D) was selected. The original ligand 
was removed and the DNA sequence was utilized for the docking experiments. Ten different 
structures of planar bicyclic or tricyclic ring systems belonging to classes 1-4 were selected. Our 
choice was driven by the consideration that although pyrrolo[2,3-d]pyrimidine and pyrrolo[3,2-
d]pyrimidine derivatives have been extensively studied as potential pharmaceuticals,14 being 
related to deazaguanine, only few reports can be found in literature on indolo[2,3-d]pyrimidines 
and indolo[3,2-d]pyrimidines.15 In any case however nothing has been reported on interaction 
with DNA of these classes of compounds and derivatives of type 1-4 are unknown. 
All the ligands and related substituents on the basic structures 1-4, utilized in this study, were 
chosen also in view of the easiness of synthetic procedure. In fact all these compounds could be 
accessible from known16-19 2- and 3-aminoindoles/pyrroles, ortho-ethoxycarbonyl substituted, of 
type 5 and 7 and the versatile BMMAs (N-(BisMethylthio)Methylenamino Acids) of type 6 
according to the procedure already successfully employed in our laboratory on 2- and 3-
aminopyrroles ortho-cyano substituted20 (Scheme 1). This method allows a one pot synthesis of 




































Scheme 1. Synthetic entry to derivatives 1-4. 
Issue in Honor of Prof. Vincenzo Tortorella ARKIVOC 2004 (v) 263-271 
ISSN 1424-6376 Page 267 ©ARKAT USA, Inc 
These docking experiments allowed to estimate the interaction energies between DNA 
fragment and the different ligands. The energies used, and reported by Autodock, can be 
distinguished in docked energies, which include the intermolecular and intramolecular 
interaction energies and are used during the dockings, and predicted free energies, which include 
the intermolecular energy and the torsional free energy, and are reported at the end of the 
docking. The predicted binding free energy of the lowest energy docked structure for each ligand 
considered in this study is reported in Table 1. 
The calculated free energy change of binding was found in the range -8.39 ÷ -16.72 Kcal/mol 
and is compatible with the value obtained by us in this study for Actinomycin D (-
10.37 Kcal/mol). Considering the different types of chains, generally a regular increase of the 
binding affinity in homologous series is observed (cf columns A-C). Only in the case of the two 
derivatives 4g and 4h the propionate (B, X=CH2-CH2) showed the higher value in the series. The 
introduction of a methyl in the side chain did not significantly effect the DNA binding capability 
(entries A and E); also generally the bioisosteric NMe derivatives (entry D) showed ∆G values 
higher than the corresponding C-substituted (entry E) or similar to the methylene analogs (entry 
A). However in isomeric series the branched side chains are less efficient in bringing about the 
interaction with the DNA minor groove (cf entries B and E, C and F). 
 















1 -14.21 -16.07 -16.36 -13.20 -14.10 -15.28 
2a -9.71 -12.02 -12.44 -9.91 -10.26 -9.07 
2b -10.56 -11.18 -12.01 -8.98 -10.79 -10.74 
2c -9.76 -10.79 -11.62 -10.88 -10.06 -9.80 
2d -13.12 -13.19 -15.37 -12.38 -13.22 -13.06 
3 -14.83 -15.63 -16.72 -14.31 -14.58 -15.56 
4e -8.39 -10.29 -10.31 -9.32 -9.73 -11.12 
4f -8.82 -10.16 -11.51 -10.25 -10.52 -10.27 
4g -10.31 -11.69 -11.24 -11.21 -10.61 -10.72 
4h -10.68 -10.97 -10.10 -11.93 -12.27 -11.20 
 
The more interesting compounds resulted to belong to the indolo-pyrimidine series 1 and 3 in 
which a larger planar system is present. This is not surprising although the phenyl rings present 
in several of our pyrrolo-pyrimidine derivatives can mimic a wider conjugated system being 
nearly coplanar with the bycycle in most of the docked structures. However it is worthy to note 
that generally the N-benzyl series of pyrrolo[3,2-d]pyrimidine 4h showed affinity higher than 
NH compounds. Of the pyrrolo-pyrimidines only compound 2dC showed a ∆G value, -
15.37 Kcal/mol, comparable with those of the indolo-pyrimidine classes. 
The ligand with the highest affinity was demonstrated to be derivative 3C (X= CH2-CH2-
CH2), which had ∆G = -16.72 Kcal/mol, and that therefore can be expected to form a complex 
Issue in Honor of Prof. Vincenzo Tortorella ARKIVOC 2004 (v) 263-271 
ISSN 1424-6376 Page 268 ©ARKAT USA, Inc 
with DNA more stable than that formed by Actinomycin D (∆G = -10.37 Kcal/mol) with the 
same DNA fragment. In all the cases the indolo- and pyrrolo-pyrimidines were shown to assume 
a spatial arrangement in which the planar heterocyclic moiety intercalates in GC portion of the 
DNA sequence whereas the side chain lies close to the minor groove. Figure 2 (right) shows the 
DNA-binding mode for the most interesting derivative 3C. 
In order to rationalize structure-binding capability relationships, for all the compounds we 
calculated the LUMO and HOMO energies, considering that these variables are of importance 
when two molecules with π electron systems form charge-transfer complexes, especially in the 
case of DNA-interactive compounds. We utilized the structures of the ligands and of some 
known intercalators (Actinomycin D included), optimized in vacuo by SCF calculation with 
PM3 method.21 It was impossible to find a linear or simple correlation between the ∆G and 
energy values, however in the case of the more interesting series, the indolo-pyrimidines 1 and 3, 
the range of HOMO energies was similar to that obtained for the reference drugs although the 
LUMO values resulted higher (Table 2). These findings further confirm the interest in the classes 
of compounds described herein as DNA-interactive polycycles. 
                
 
Figure 2. Stick view of ten superpositioned best scores (left) and best structure docked to DNA-
fragment (right) for derivative 3C. 
 
Table 2. Calculated HOMO and LUMO energies (eV) 
Compounds HOMO LUMO 
1 -8.43 ÷ -8.61 -0.71 ÷ -0.90 
3 -8.20 ÷ -8.34 -0.76 ÷ -0.89 
Reference drugs -8.48 ÷ -9.08 -1.16 ÷ -1.57 
 
 
Issue in Honor of Prof. Vincenzo Tortorella ARKIVOC 2004 (v) 263-271 
ISSN 1424-6376 Page 269 ©ARKAT USA, Inc 
Conclusions 
 
In conclusion these classes of compounds combine two of the main features of DNA-interactive 
drugs and very tight DNA-binding capability has to be expected. The docking studies revealed a 
common binding mode with the chromophore intercalated between GC base pairs whereas the 
side chain lies along the minor groove. The more interesting new derivatives of the series will be 
synthesized and submitted for DNA-binding assays. The docking studies reported herein 
provided reliable information on the capability of new ligands to interact with DNA allowing us 





Ligand setup. The 3D structures of the ligands were constructed, pre-optimized with 
implemented MM2 force field and further refined using Vega 1.5.22 The PM3 method was used 
for geometry optimization and charge calculation. To allow flexibility in the ligand, it is 
necessary to assign the routable bonds; however in our case all the rotamers were allowed. 
DNA fragment setup. The PDB file of the selected structure 1DSC was downloaded from the 
database and the ligand was removed from the fragment. The resulting macromolecule was setup 
for docking as follows: polar hydrogens were added using the PROTONATE utility. Solvation 
parameters were added to the final protein file using the ADDSOL utility of AutoDock. 
The grid maps representing the protein in the actual docking process were calculated with 
AutoGrid. The grids (one for each atom type in the ligand, plus one for electrostatic interactions) 
were chosen to be sufficiently large to include not only the active site but also significant 
portions of the surrounding surface. The points of the grids were thus 60 × 60 × 60, with a grid 
spacing of 0.375 Å. 
Docking. Docking of the ligands into receptor was carried out using AutoDock (version 3.0.5) 
set of programs.12 It was carried out using the empirical free energy function and the Lamarckian 
genetic algorithm (LGA),13 applying a standard protocol, with an initial population of 100 
randomly placed individuals, a maximum number of 1.5 × 106 energy evaluations, a mutation 
rate of 0.02, a crossover rate of 0.80, and an elitism value of 1. Proportional selection was used, 
where the average of the worst energy was calculated over a window of the previous 10 
generations. For the local search, the so-called pseudo-Solis and Wets algorithm23 was applied 
using a maximum of 300 iterations per local search. The probability of performing local search 
on an individual in the population was 0.06, and the maximum number of consecutive successes 
or failures before doubling or halving the local search step size was 4. Ten independent docking 
runs were carried out for each ligand. At the end of each AutoDock execution, in which more 
than one run was performed, the program outputs a list of clusters and their energies. The 
clustering of docked conformations is determined by the tolerance specified in Å. In our cases 
the results differing by less than 1.0 Å in positional root-mean-square deviation (rmsd) were 
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clustered together and represented by the result with the most favourable free energy of binding. 
The best representative from each cluster (the one with the lowest energy) is written out in 
PDBQ format at the end of the log file.24 These structures can be read into any appropriate 
molecular modelling system. The table of ranked clusters shows the final docked energy for each 
conformation, and the RMS difference between the lowest energy member of the group and 
every other member. The RMS for the lowest member of the group is by definition zero. After 
this table, the structures are output in PDBQ format. Each conformation has a set of remark 
records, one of which describes the RMS difference between itself and the coordinates specified 
in the original input PDBQ file. 
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